Valuation: BioElectronics Corporation

Market Cap 1.24Cr 1.08Cr 99.81L 93.1L 1.75Cr 116.8Cr 1.79Cr 12Cr 4.65Cr 58Cr 4.64Cr 4.54Cr 200.78Cr P/E 2020
-26.5x
P/E 2021 -95.5x
Enterprise Value 2.57Cr 2.25Cr 2.08Cr 1.94Cr 3.65Cr 242.94Cr 3.71Cr 25Cr 9.67Cr 119.88Cr 9.65Cr 9.44Cr 417.65Cr EV / Sales 2020
53.6x
EV / Sales 2021 24.2x
Free-Float
100%
Yield 2020 *
-
Yield 2021 -
1 day+20.00%
1 week-25.00%
1 month-25.00%
3 months-25.00%
6 months-25.00%
Current year-25.00%
1 week 0
Extreme 0.0002
0
1 month 0
Extreme 0.0002
0
Current year 0
Extreme 0.0002
0
1 year 0
Extreme 0.0001
0
3 years 0
Extreme 0.0001
0
5 years 0
Extreme 0.0001
0
10 years 0
Extreme 0.0001
0.01
Manager TitleAgeSince
Chief Executive Officer - 15/11/2019
Sales & Marketing - 01/09/2017
Corporate Officer/Principal - -
Director TitleAgeSince
Director/Board Member - 15/11/2019
Chairman 85 15/06/2020
Director/Board Member - 03/12/2024
Change 5-day change 1-year change 3-year change Capi.($)
+20.00%-25.00%+50.00%-50.00% 74.12L
-1.00%+6.82%+23.65%-3.91% 19TCr
-2.04%-1.36%-26.82%+16.30% 14TCr
-1.19%+6.43%-3.57%-20.63% 13TCr
-1.84%-6.40%-60.26%-21.09% 6.34TCr
-0.79%+4.04%+15.66%-4.10% 5.21TCr
-1.07%-1.37%-28.05%-33.39% 4.36TCr
-.--%+4.86%+12.56%+10.46% 3.75TCr
+1.67%+4.99%+7.45%+40.71% 3.68TCr
-1.60%+0.46%-13.58%-21.21% 2.91TCr
Average +2.00%+0.88%-2.30%-8.69% 7.25TCr
Weighted average by Cap. +0.05%+3.86%-5.15%-4.07%

Financials

2020 2021
Net sales 8L 7L 7L 6L 11.78L 7.84Cr 11.99L 80.4L 31.21L 3.87Cr 31.17L 30.47L 13Cr 16.09L 14.09L 13L 12.13L 22.86L 15Cr 23.26L 1.56Cr 60.56L 7.51Cr 60.47L 59.12L 26Cr
Net income -11.6L -10.15L -9L -9L -16.47L -11Cr -16.76L -1.12Cr -43.64L -5.41Cr -43.57L -42.6L -19Cr -3L -3L -2L -2L -4L -2.74Cr -4L -28.09L -10.91L -1.35Cr -10.89L -10.65L -4.71Cr
Net Debt 1.31Cr 1.14Cr 1.06Cr 98.49L 1.86Cr 123.56Cr 1.89Cr 13Cr 4.92Cr 61Cr 4.91Cr 4.8Cr 212.41Cr 1.33Cr 1.17Cr 1.08Cr 1.01Cr 1.89Cr 126.15Cr 1.93Cr 13Cr 5.02Cr 62Cr 5.01Cr 4.9Cr 216.86Cr
Logo BioElectronics Corporation
BioElectronics Corporation is an electroceutical company, which develops wearable, neuromodulation devices to safely mitigate neurological diseases. Its pulsed shortwave therapy technology (PSWT) uses low-power pulsed electromagnetic fields to regulate electrical activity of the nervous system. The Company’s product line includes ActiPatch Musculoskeletal Pain Therapy, and RecoveryRx Post-operative and Chronic Wounds Therapy, which are sold by or on the order of medical professionals. PSWT is a non-invasive electromagnetic therapy designed to reduce pain and enhance life in patients with chronic musculoskeletal conditions. PSWT has no systemic side effects and can be self-administered at home. The ActiPatch product provides advanced long-lasting pain relief using Electromagnetic Pulse Therapy and works great for back pain, knee pain, muscle & joint pain, arthritis, sciatica, fibromyalgia, strains, sprains and more.
Employees
9
Date Price Change Volume
30/26/30 $0.000300 +20.00% 93,58,333
29/26/29 $0.000250 -.--% 69,30,833
26/26/26 $0.000250 -16.67% 43,50,000
25/26/25 $0.000300 -.--% 45,01,604
24/26/24 $0.000300 -14.29% 11,87,57,219
  1. Stock Market
  2. Stocks
  3. BIEL Stock